Sunitinib therapy in renal cell carcinoma.
O'Brien
Matthew F
MF
Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA.
Russo
Paul
P
Motzer
Robert J
RJ
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002292:Carcinoma, Renal Cell / Q000628:therapy*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000628:therapy*; D008297:Male; D009392:Nephrectomy / Q000379:methods; D011758:Pyrroles / Q000627:therapeutic use*; D000077210:Sunitinib; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D007211:Indoles; D011758:Pyrroles; D000077210:Sunitinib